Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial

Summary Aim To examine whether the velocity of saccadic eye movements in internuclear ophthalmoparesis ( INO ) improves with fampridine treatment in patients with multiple sclerosis ( MS ). Methods Randomized, double‐blind, placebo‐controlled, cross‐over trial with fampridine in patients with MS and INO . Horizontal saccades were recorded at baseline and at multiple time points post‐dose. Main outcome measures were the change of peak velocity...